Board of Scientific Counselors, National Center for Infectious Diseases, 15327 [05-5909]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 57 / Friday, March 25, 2005 / Notices
15327
TABLE 1.—FRAMEWORK FOR EQUIVALENT PROTECTIONS—Continued
Specific protection
Example procedures
45 CFR part 46 subpart A authority
46.111(a)(4) Informed consent will be sought from each prospective
subject or the subject’s legally authorized representative, in accordance with, and to the extent required by § 46.116.
46.116(a)(1–8) Necessary elements of disclosure.
46.116(b)(1–6) Necessary elements of disclosure.
46.116(c)(1–2) Waiver of informed consent.
46.116(d)(1–4) Approval of alternate consent procedures or waiver.
46.117(a) Written informed consent.
Bernard A. Schwetz,
Director, Office for Human Research
Protections.
[FR Doc. 05–5947 Filed 3–24–05; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
The National Center for Chronic
Disease Prevention and Health
Promotion
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
following meeting.
Name: Interagency Committee on Smoking
and Health.
Time and Date: 9 a.m.–4:30 p.m., April 13,
2005.
Place: Omni Shoreham Hotel, Hampton
Ballroom, 2500 Calvert Street, NW.,
Washington, DC 20008. Telephone: 202–234–
0700.
Status: Open to the public, limited only by
the space available. Those who wish to
attend are encouraged to register with the
contact person listed below. If you will
require a sign language interpreter, or have
other special needs, please notify the contact
person by 4:30 e.s.t. on April 4, 2005.
Purpose: The Interagency Committee on
Smoking and Health advises the Secretary,
Department of Health and Human Services,
and the Assistant Secretary for Health in the
(a) coordination of all research and education
programs and other activities within the
Department and with other Federal, State,
local and private agencies and (b)
establishment and maintenance of liaison
with appropriate private entities, Federal
agencies, and State and local public health
agencies with respect to smoking and health
activities.
Matters to be Discussed: The agenda will
focus on addressing the Global Tobacco
Epidemic.
For Further Information Contact:
Substantive program information as well as
summaries of the meeting and roster of
committee members may be obtained from
the Internet at https://www.cdc.gov/tobacco in
mid-May or from Ms. Monica L. Swann,
Management and Program Analyst, Office on
VerDate jul<14>2003
16:11 Mar 24, 2005
Jkt 205001
Smoking and Health, 200 Independence
Avenue, SW., Suite 317B, Washington, DC
20201, (202) 205–8500.
Agenda items are subject to change as
priorities dictate.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: March 18, 2005.
Alvin Hall,
Director, Management Analysis and Service
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–5913 Filed 3–24–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Infectious Diseases
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
Name: Board of Scientific Counselors,
National Center for Infectious Diseases
(NCID).
Times and Dates: 9 a.m.–5:30 p.m., May
12, 2005. 8:30 a.m.–2 p.m., May 13, 2005.
Place: CDC, Auditorium B, Building 1,
1600 Clifton Road, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Board of Scientific
Counselors, NCID, provides advice and
guidance to the Director, CDC, and Director,
NCID, in the following areas: program goals
and objectives; strategies; program
organization and resources for infectious
disease prevention and control; and program
priorities.
Matters To Be Discussed: Agenda items
will include:
1. Opening Session: NCID Update.
2. Futures Initiative Update.
3. Environmental Microbiology.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
4. Development of CDC Research Agenda.
5. Veterinary-Human Public Health
Interface.
6. Global Disease Detection Initiative.
7. Topic Updates.
a. Influenza.
b. Chronic Wasting Disease.
c. Quarantine Update.
8. Board meets with Director, CDC.
Other agenda items include
announcements/introductions; follow-up on
actions recommended by the Board
December 2004; consideration of future
directions, goals, and recommendations.
Agenda items are subject to change as
priorities dictate.
Written comments are welcome and should
be received by the contact person listed
below prior to the opening of the meeting.
Contact Person for More Information: Tony
Johnson, Office of the Director, NCID, CDC,
Mailstop E–51, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, e-mail
tjohnson3@cdc.gov; telephone 404/498–3249.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 18, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–5909 Filed 3–24–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–2211–N]
Medicare, Medicaid, and CLIA
Programs; Continuance of the
Approval of the American Society for
Histocompatibility and
Immunogenetics as a CLIA
Acreditation Organization
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 70, Number 57 (Friday, March 25, 2005)]
[Notices]
[Page 15327]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5909]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Infectious
Diseases
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting.
Name: Board of Scientific Counselors, National Center for
Infectious Diseases (NCID).
Times and Dates: 9 a.m.-5:30 p.m., May 12, 2005. 8:30 a.m.-2
p.m., May 13, 2005.
Place: CDC, Auditorium B, Building 1, 1600 Clifton Road,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Board of Scientific Counselors, NCID, provides
advice and guidance to the Director, CDC, and Director, NCID, in the
following areas: program goals and objectives; strategies; program
organization and resources for infectious disease prevention and
control; and program priorities.
Matters To Be Discussed: Agenda items will include:
1. Opening Session: NCID Update.
2. Futures Initiative Update.
3. Environmental Microbiology.
4. Development of CDC Research Agenda.
5. Veterinary-Human Public Health Interface.
6. Global Disease Detection Initiative.
7. Topic Updates.
a. Influenza.
b. Chronic Wasting Disease.
c. Quarantine Update.
8. Board meets with Director, CDC.
Other agenda items include announcements/introductions; follow-
up on actions recommended by the Board December 2004; consideration
of future directions, goals, and recommendations.
Agenda items are subject to change as priorities dictate.
Written comments are welcome and should be received by the
contact person listed below prior to the opening of the meeting.
Contact Person for More Information: Tony Johnson, Office of the
Director, NCID, CDC, Mailstop E-51, 1600 Clifton Road, NE., Atlanta,
Georgia 30333, e-mail tjohnson3@cdc.gov; telephone 404/498-3249.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 18, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-5909 Filed 3-24-05; 8:45 am]
BILLING CODE 4163-18-P
